Product Recalls in Pennsylvania

Product recalls affecting Pennsylvania — including food, drugs, consumer products, medical devices, and vehicles distributed to Pennsylvania. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,919 recalls have been distributed to Pennsylvania in the last 12 months.

55,602 total recalls
2,919 in last 12 months

Showing 10611080 of 13,473 recalls

DrugMay 10, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Tablets USP Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension Recalled by Bryant Ranch Prepack, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Back Label states 'Each contains:...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 8, 2024· Lupin Pharmaceuticals Inc.

Recalled Item: Cefdinir for Oral Suspension USP Recalled by Lupin Pharmaceuticals Inc. Due...

The Issue: Defective container: lack of seal integrity.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 7, 2024· PACIRA PHARMACEUTICALS INC

Recalled Item: Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release...

The Issue: Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 7, 2024· MACLEODS PHARMA USA, INC

Recalled Item: Losartan Potassium and Hydrochlorothiazide Tablets Recalled by MACLEODS...

The Issue: Presence of foreign substance: plastic-like substance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 6, 2024· Rubicon Research Private Limited

Recalled Item: Metoprolol Tartrate Tablets USP Recalled by Rubicon Research Private Limited...

The Issue: Presence of Foreign Substance: metal in tablet

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 2, 2024· RemedyRepack Inc.

Recalled Item: TraMADol HCl 50 mg Tablet Recalled by RemedyRepack Inc. Due to Presence of...

The Issue: Presence of Foreign Tablets: Manufacturer received a report from a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 1, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Sirolimus Tablets 1mg Tablets 100-count bottle Recalled by Dr. Reddy's...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 1, 2024· Pharma Nobis LLC

Recalled Item: Meijer Magnesium Citrate Saline Laxative Oral Solution Dye Free Recalled by...

The Issue: Microbial Contamination of Non-Sterile Products - Presence of Acetobacter...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 1, 2024· Pharma Nobis LLC

Recalled Item: CVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Recalled...

The Issue: Microbial Contamination of Non-Sterile Products - Presence of Acetobacter...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 30, 2024· Viatris Inc

Recalled Item: Cardura XL (doxazosin) extended release tablets 8mg Recalled by Viatris Inc...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 30, 2024· Viatris Inc

Recalled Item: Cardura XL (doxazosin) extended release tablets 4mg Recalled by Viatris Inc...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 30, 2024· Hikma Injectables USA Inc

Recalled Item: Fentanyl 1000mcg/100mL (10mcg/mL) in 0.9% Sodium Chloride Injection Recalled...

The Issue: Labeling: Wrong Barcode

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 29, 2024· Hikma Injectables USA Inc

Recalled Item: Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free Recalled...

The Issue: Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 29, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 29, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 29, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2024· Rubicon Research Private Limited

Recalled Item: traMADol Hydrochloride Tablets Recalled by Rubicon Research Private Limited...

The Issue: Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2024· Sagent Pharmaceuticals

Recalled Item: MethylPREDNISolone Acetate Injectable Suspension Recalled by Sagent...

The Issue: Presence of Particulate Matter: Potential for black particulates in the drug...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2024· Viatris Inc

Recalled Item: Valacyclovir Tablets USP Recalled by Viatris Inc Due to Failed...

The Issue: Failed Tablet/Capsule Specifications: There is a potential for the imprint,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund